decision-making

Real-world experience with switching from intravenous immunoglobulin to subcutaneous efgartigimod PH20 in patients with chronic inflammatory demyelinating polyradiculoneuropathy: A case series

Study Overview The transition from intravenous immunoglobulin (IVIg) to subcutaneous efgartigimod PH20 in patients diagnosed with chronic inflammatory demyelinating polyradiculoneuropathy

Real-world experience with switching from intravenous immunoglobulin to subcutaneous efgartigimod PH20 in patients with chronic inflammatory demyelinating polyradiculoneuropathy: A case series Read Post »

Epidemiology, Patient Characteristics, Real-World Treatment Patterns, and Healthcare Utilization and Spending for Patients with Multifocal Motor Neuropathy: A US Claims-Based Analysis

Clinical Characteristics The patient population affected by multifocal motor neuropathy (MMN) exhibits distinctive clinical features that are critical for understanding

Epidemiology, Patient Characteristics, Real-World Treatment Patterns, and Healthcare Utilization and Spending for Patients with Multifocal Motor Neuropathy: A US Claims-Based Analysis Read Post »

Scroll to Top